SANDRA HAUPT: Open Payments
NPI 1689901639 · MONROE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$239 in 12 payments from 10 companies in 2025. Trend: 2023 $254 · 2024 $248 · 2025 $239
Food & beverage: $239
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $43 |
| Dexcom, Inc. | 2 | $40 |
| Astellas Pharma US Inc | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: Dexcom G6 Transmitter, Veozah, TRELEGY ELLIPTA, QULIPTA, JARDIANCE, VRAYLAR, XIFAXAN, FARXIGA.
Industry payments across GA — which companies pay providers there.
